Keratoacanthoma centrifugum marginatum accompanied by extensive granulomatous foreign body reaction

Dermatology Online Journal

Volumn 11, Issue 2, 2005, Pages

  Kurschat, P ^a   Hess, S ^a   Hunzelmann, N ^a   Scharffetter Kochanek, K ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KERATIN; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; CYTOPATHOLOGY; DISEASE COURSE; FEMALE; FOREIGN BODY REACTION; GRANULOMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATOACANTHOMA; KERATOACANTHOMA CENTRIFUGUM MARGINATUM; PAPULE; PARAKERATOSIS; POLYMERASE CHAIN REACTION; WART VIRUS;

FACIAL DERMATOSES; FEMALE; GRANULOMA, FOREIGN-BODY; HUMANS; KERATOACANTHOMA; MIDDLE AGED;

EID: 24044456038     PISSN: 10872108     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ghadially FN: Keratoacanthoma. In: Fitzpatrick TB, Eisen AZ, Wolff K et al., eds. Dermatology in general medicine, 2nd ed. New York: McGraw-Hill, 1979; 383.
2. Esche C, Kruse R, Lamberti C, Friedl W, Propping P, Lehmann P, Ruzicka T: Muir-Torre syndrome: clinical features and molecular genetic analysis. Br J Dermatol 1997; 136 (6): 913-917.
3. Stephenson TJ, Royds J, Silcocks PB, Bleehen SS: Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma. Br J Dermatol 1993; 127 (6): 566-570.
4. Mc Gregor JM, Farthing A, Crook T, Yu CC, Dublin EA, Levison DA, MacDonald DM: Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomaviruses. J Am Acad Dermatol 1994; 30: 701-706.
5. Corominas M, Sloan SR, Leon J, Kamino H, Newcomb EW, Pellicer A: Ras activation in human tumors and in animal model systems. Environ Health Perspect 1991; 93: 19-25.
6. Chalet MD, Connors RC, Ackerman AB: Squamous cell carcinoma vs. keratoacanthoma: Criteria for histologic differentiation. J Dermatol Surg 1975; 1: 16.
7. Kern WH, McGray MK: The histopathologic differentiation of keratoacanthoma and squamous cell carcioma of the skin. J Cutan Pathol 1980; 7: 318.
8. Cribier B, Asch P, Grosshans E: Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology 1999; 199 (3): 208-212.
9. Belisario JC: Brief review of keratoacanthomas and description of keratoacanthoma centrifugum marginatum. Aust J Dermatol 1965; 8: 65-75.
10. Janecka IP, Wolff M, Crickelair GF, Cosmann B: Aggressive histological features of keratoacanthoma. J Cutan Pathol 1977; 4: 342-348.
11. Giltman LI: Tripolar mitosis in keratoacanthoma. Acta Derm Venereol 1981; 61: 362-363.
12. Lapins NA, Helwig EB : Perineural invasion by keratoacanthoma. Arch Dermatol 1980; 116: 791-793.
13. Drolet BA, Neuburg M, Sanger J: Role of human papillomavirus in cutaneous oncogenesis. Ann Plast Surg 1994; 33: 339-347.
14. Hsi ED, Svoboda-Newman SM, Stern RA, Nickoloff BJ, Frank TS: Detection of human papillomavirus DNA in keratoacanthomas by polymerase chain reaction. Am J Dermatopathol 1997; 19: 10-15.
15. Lu S, Syrjanen SL, Havu VK, Syrjanen S: Known HPV types have no association with keratoacanthomas. Arch Dermatol Res 1996; 288: 129-132.
16. Stockfleth E, Meinke B, Arndt R, Christophers E, Meyer T: Identification of DNA sequences of both genital and cutaneous HPV types in a small number of keratoacanthomas of nonimmunosuppressed patients. Dermatology 1999; 198 (2): 122-125.
17. Lo Shiavo A, Pinto F, Degner AM, Bucci M, Ruocco V: Keratoacanthoma centrifugum marginatum. Possible etiological role of papillomavirus and therapeutic response to etretinate. Ann Dermatol Venereol 1996; 123: 660-663.